MIVERIAN Trademark

Trademark Overview

On Friday, March 14, 2008, a trademark application was filed for MIVERIAN with the United States Patent and Trademark Office. The USPTO has given the MIVERIAN trademark a serial number of 77422187. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, January 13, 2017. This trademark is owned by AstraZeneca AB. The MIVERIAN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of oncological diseases, cardiovascular diseases, respiratory diseases, inflammation and infection, gastrointestinal diseases and central nervous system diseases
miverian

General Information

Serial Number77422187
Word MarkMIVERIAN
Filing DateFriday, March 14, 2008
Status710 - CANCELLED - SECTION 8
Status DateFriday, January 13, 2017
Registration Number3798055
Registration DateTuesday, June 8, 2010
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 11, 2009

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of oncological diseases, cardiovascular diseases, respiratory diseases, inflammation and infection, gastrointestinal diseases and central nervous system diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, January 13, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca AB
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSodertalje SE-151-85
SE
Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSodertalje SE-151-85
SE
Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSodertalje SE-151-85
SE

Trademark Events

Event DateEvent Description
Friday, January 13, 2017CANCELLED SEC. 8 (6-YR)
Tuesday, June 8, 2010REGISTERED-PRINCIPAL REGISTER
Tuesday, May 4, 20101(B) BASIS DELETED; PROCEED TO REGISTRATION
Monday, May 3, 2010NOTICE OF ALLOWANCE CANCELLED
Tuesday, May 4, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, May 3, 2010TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, November 3, 2009NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 11, 2009PUBLISHED FOR OPPOSITION
Wednesday, July 22, 2009NOTICE OF PUBLICATION
Wednesday, July 8, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, July 6, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 22, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 22, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 22, 2009TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, December 22, 2008NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, December 22, 2008INQUIRY TO SUSPENSION E-MAILED
Monday, December 22, 2008SUSPENSION INQUIRY WRITTEN
Tuesday, June 10, 2008NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, June 10, 2008LETTER OF SUSPENSION E-MAILED
Tuesday, June 10, 2008SUSPENSION LETTER WRITTEN
Tuesday, June 10, 2008EXAMINER'S AMENDMENT ENTERED
Tuesday, June 10, 2008NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, June 10, 2008EXAMINERS AMENDMENT E-MAILED
Tuesday, June 10, 2008EXAMINERS AMENDMENT -WRITTEN
Thursday, May 15, 2008ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, May 15, 2008TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 30, 2008NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 30, 2008NON-FINAL ACTION E-MAILED
Wednesday, April 30, 2008NON-FINAL ACTION WRITTEN
Monday, April 28, 2008ASSIGNED TO EXAMINER
Wednesday, April 2, 2008AMENDMENT FROM APPLICANT ENTERED
Wednesday, April 2, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 2, 2008ASSIGNED TO LIE
Friday, March 28, 2008PAPER RECEIVED
Wednesday, March 19, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

miverian diseases gastrointestinal infection central system nervous inflammation respiratory preparations treatment